title: [Sweet's syndrome and multiple myeloma].
authors.forename: J
authors.initials: J
authors.lastname: Borbujo
authors.forename: R
authors.initials: R
authors.lastname: de Lucas
authors.forename: R
authors.initials: R
authors.lastname: Manzano
authors.forename: M
authors.initials: M
authors.lastname: Casado
mesh_terms: D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D006801:Humans; D007146:Immunoglobulin lambda-Chains / Q000276:immunology; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000008:administration & dosage; D016463:Sweet Syndrome / Q000150:complications* / Q000188:drug therapy; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D007146:Immunoglobulin lambda-Chains; D008558:Melphalan; D011241:Prednisone
vernacular_title: Síndrome de sweet y mieloma múltiple.